Novavax, Inc. (NVAX)
USD 6.22
(10.98%)
USD 6.22
(10.98%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.57 Billion USD | -11.08% |
| 2022 | 2.89 Billion USD | -1.22% |
| 2021 | 2.92 Billion USD | 206.55% |
| 2020 | 955.27 Million USD | 166.11% |
| 2019 | 358.97 Million USD | -4.51% |
| 2018 | 375.91 Million USD | -7.0% |
| 2017 | 404.22 Million USD | 1.09% |
| 2016 | 399.84 Million USD | 328.24% |
| 2015 | 93.36 Million USD | 101.3% |
| 2014 | 46.38 Million USD | 41.83% |
| 2013 | 32.7 Million USD | 47.94% |
| 2012 | 22.1 Million USD | 73.69% |
| 2011 | 12.72 Million USD | -19.42% |
| 2010 | 15.79 Million USD | 41.78% |
| 2009 | 11.14 Million USD | -64.22% |
| 2008 | 31.13 Million USD | 10.31% |
| 2007 | 28.22 Million USD | 1.26% |
| 2006 | 27.87 Million USD | -19.74% |
| 2005 | 34.73 Million USD | -22.33% |
| 2004 | 44.71 Million USD | -7.27% |
| 2003 | 48.21 Million USD | -2.46% |
| 2002 | 49.43 Million USD | 24.76% |
| 2001 | 39.62 Million USD | 60.38% |
| 2000 | 24.7 Million USD | 1353.24% |
| 1999 | 1.7 Million USD | 112.5% |
| 1998 | 800 Thousand USD | 166.67% |
| 1997 | 300 Thousand USD | -50.0% |
| 1996 | 600 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.22 Billion USD | -13.67% |
| 2024 Q2 | 2.25 Billion USD | 1.34% |
| 2023 Q1 | 2.43 Billion USD | -15.71% |
| 2023 Q4 | 2.57 Billion USD | 10.14% |
| 2023 Q3 | 2.33 Billion USD | -4.27% |
| 2023 Q2 | 2.43 Billion USD | 0.05% |
| 2023 FY | 2.57 Billion USD | -11.08% |
| 2022 FY | 2.89 Billion USD | -1.22% |
| 2022 Q3 | 2.83 Billion USD | -6.79% |
| 2022 Q4 | 2.89 Billion USD | 2.09% |
| 2022 Q1 | 2.76 Billion USD | -5.43% |
| 2022 Q2 | 3.03 Billion USD | 9.76% |
| 2021 Q4 | 2.92 Billion USD | 39.14% |
| 2021 FY | 2.92 Billion USD | 206.55% |
| 2021 Q1 | 1.56 Billion USD | 64.27% |
| 2021 Q2 | 2 Billion USD | 27.71% |
| 2021 Q3 | 2.1 Billion USD | 5.02% |
| 2020 FY | 955.27 Million USD | 166.11% |
| 2020 Q3 | 837.58 Million USD | 12.02% |
| 2020 Q2 | 747.7 Million USD | 112.39% |
| 2020 Q1 | 352.03 Million USD | -1.93% |
| 2020 Q4 | 955.27 Million USD | 14.05% |
| 2019 Q1 | 371.9 Million USD | -1.07% |
| 2019 FY | 358.97 Million USD | -4.51% |
| 2019 Q4 | 358.97 Million USD | 1.22% |
| 2019 Q3 | 354.64 Million USD | -5.4% |
| 2019 Q2 | 374.88 Million USD | 0.8% |
| 2018 FY | 375.91 Million USD | -7.0% |
| 2018 Q1 | 375.43 Million USD | -7.12% |
| 2018 Q2 | 373.51 Million USD | -0.51% |
| 2018 Q3 | 377.15 Million USD | 0.98% |
| 2018 Q4 | 375.91 Million USD | -0.33% |
| 2017 Q1 | 390.6 Million USD | -2.31% |
| 2017 Q4 | 404.22 Million USD | -0.98% |
| 2017 Q3 | 408.22 Million USD | -1.58% |
| 2017 FY | 404.22 Million USD | 1.09% |
| 2017 Q2 | 414.76 Million USD | 6.19% |
| 2016 FY | 399.84 Million USD | 328.24% |
| 2016 Q4 | 399.84 Million USD | -2.44% |
| 2016 Q2 | 414.88 Million USD | 1.92% |
| 2016 Q1 | 407.07 Million USD | 335.98% |
| 2016 Q3 | 409.84 Million USD | -1.22% |
| 2015 FY | 93.36 Million USD | 101.3% |
| 2015 Q1 | 39.13 Million USD | -15.63% |
| 2015 Q4 | 93.36 Million USD | 148.2% |
| 2015 Q2 | 37.09 Million USD | -5.21% |
| 2015 Q3 | 37.61 Million USD | 1.41% |
| 2014 Q4 | 46.38 Million USD | 50.29% |
| 2014 FY | 46.38 Million USD | 41.83% |
| 2014 Q3 | 30.86 Million USD | 2.0% |
| 2014 Q2 | 30.26 Million USD | 9.88% |
| 2014 Q1 | 27.53 Million USD | -15.79% |
| 2013 Q3 | 28.5 Million USD | 20.29% |
| 2013 FY | 32.7 Million USD | 47.94% |
| 2013 Q4 | 32.7 Million USD | 14.75% |
| 2013 Q2 | 23.69 Million USD | 12.09% |
| 2013 Q1 | 21.13 Million USD | -4.38% |
| 2012 Q4 | 22.1 Million USD | 15.31% |
| 2012 Q1 | 14.31 Million USD | 12.46% |
| 2012 FY | 22.1 Million USD | 73.69% |
| 2012 Q2 | 15.89 Million USD | 11.07% |
| 2012 Q3 | 19.17 Million USD | 20.58% |
| 2011 FY | 12.72 Million USD | -19.42% |
| 2011 Q1 | 16.6 Million USD | 5.15% |
| 2011 Q2 | 13.07 Million USD | -21.27% |
| 2011 Q3 | 12.48 Million USD | -4.49% |
| 2011 Q4 | 12.72 Million USD | 1.91% |
| 2010 Q2 | 11.42 Million USD | -6.67% |
| 2010 Q3 | 12.32 Million USD | 7.87% |
| 2010 Q4 | 15.79 Million USD | 28.19% |
| 2010 Q1 | 12.23 Million USD | 9.86% |
| 2010 FY | 15.79 Million USD | 41.78% |
| 2009 Q4 | 11.14 Million USD | 25.69% |
| 2009 FY | 11.14 Million USD | -64.22% |
| 2009 Q1 | 30.16 Million USD | -3.11% |
| 2009 Q3 | 8.86 Million USD | -34.35% |
| 2009 Q2 | 13.5 Million USD | -55.25% |
| 2008 FY | 31.13 Million USD | 10.31% |
| 2008 Q2 | 33.55 Million USD | 10.29% |
| 2008 Q1 | 30.42 Million USD | 7.79% |
| 2008 Q3 | 33.38 Million USD | -0.5% |
| 2008 Q4 | 31.13 Million USD | -6.74% |
| 2007 Q4 | 28.22 Million USD | 1.45% |
| 2007 Q3 | 27.82 Million USD | 0.15% |
| 2007 Q2 | 27.78 Million USD | -1.76% |
| 2007 FY | 28.22 Million USD | 1.26% |
| 2007 Q1 | 28.27 Million USD | 1.44% |
| 2006 Q3 | 26.24 Million USD | -1.88% |
| 2006 Q4 | 27.87 Million USD | 6.23% |
| 2006 Q1 | 26.32 Million USD | -24.2% |
| 2006 FY | 27.87 Million USD | -19.74% |
| 2006 Q2 | 26.74 Million USD | 1.59% |
| 2005 FY | 34.73 Million USD | -22.33% |
| 2005 Q3 | 40.64 Million USD | -2.31% |
| 2005 Q4 | 34.73 Million USD | -14.55% |
| 2005 Q2 | 41.6 Million USD | -1.37% |
| 2005 Q1 | 42.18 Million USD | -5.66% |
| 2004 FY | 44.71 Million USD | -7.27% |
| 2004 Q2 | 51.27 Million USD | 6.72% |
| 2004 Q1 | 48.05 Million USD | -0.34% |
| 2004 Q3 | 44.05 Million USD | -14.08% |
| 2004 Q4 | 44.71 Million USD | 1.48% |
| 2003 Q3 | 48.73 Million USD | 1.98% |
| 2003 Q4 | 48.21 Million USD | -1.06% |
| 2003 Q1 | 48.34 Million USD | -2.21% |
| 2003 FY | 48.21 Million USD | -2.46% |
| 2003 Q2 | 47.78 Million USD | -1.15% |
| 2002 Q3 | 49.19 Million USD | -2.15% |
| 2002 Q4 | 49.43 Million USD | 0.49% |
| 2002 FY | 49.43 Million USD | 24.76% |
| 2002 Q1 | 39.86 Million USD | 0.6% |
| 2002 Q2 | 50.27 Million USD | 26.12% |
| 2001 FY | 39.62 Million USD | 60.38% |
| 2001 Q1 | 24.05 Million USD | -2.62% |
| 2001 Q3 | 38.83 Million USD | 38.18% |
| 2001 Q2 | 28.1 Million USD | 16.82% |
| 2001 Q4 | 39.62 Million USD | 2.03% |
| 2000 Q1 | 1.4 Million USD | -17.29% |
| 2000 Q2 | 1.71 Million USD | 21.91% |
| 2000 Q3 | 2.02 Million USD | 18.26% |
| 2000 Q4 | 24.7 Million USD | 1118.8% |
| 2000 FY | 24.7 Million USD | 1353.24% |
| 1999 FY | 1.7 Million USD | 112.5% |
| 1999 Q4 | 1.7 Million USD | 70.0% |
| 1999 Q3 | 1 Million USD | 233.33% |
| 1999 Q1 | 900 Thousand USD | 12.5% |
| 1999 Q2 | 300 Thousand USD | -66.67% |
| 1998 Q4 | 800 Thousand USD | 300.0% |
| 1998 FY | 800 Thousand USD | 166.67% |
| 1998 Q2 | 300 Thousand USD | 0.0% |
| 1998 Q1 | 300 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | -33.33% |
| 1997 Q2 | 500 Thousand USD | 25.0% |
| 1997 Q1 | 400 Thousand USD | -33.33% |
| 1997 FY | 300 Thousand USD | -50.0% |
| 1997 Q3 | 200 Thousand USD | -60.0% |
| 1997 Q4 | 300 Thousand USD | 50.0% |
| 1996 FY | 600 Thousand USD | 0.0% |
| 1996 Q4 | 600 Thousand USD | 50.0% |
| 1996 Q3 | 400 Thousand USD | -20.0% |
| 1996 Q1 | 500 Thousand USD | 0.0% |
| 1996 Q2 | 500 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -666.067% |
| Alkermes plc | 933.53 Million USD | -175.54% |
| Agenus Inc. | 462.29 Million USD | -456.413% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 36.495% |
| Aptorum Group Limited | 5.25 Million USD | -48832.798% |
| Ardelyx, Inc. | 130.76 Million USD | -1867.123% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -437.693% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1046.226% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1875.477% |
| ChromaDex Corporation | 26.5 Million USD | -9603.746% |
| Chimerix, Inc. | 19.74 Million USD | -12927.445% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -7212.336% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -3444.681% |
| CRISPR Therapeutics AG | 346.76 Million USD | -641.784% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1725.34% |
| Dyadic International, Inc. | 2.34 Million USD | -109795.452% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -15716.694% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1450.129% |
| Lantern Pharma Inc. | 2.73 Million USD | -93789.327% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -3498.586% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -72795.139% |
| Incyte Corporation | 1.59 Billion USD | -61.547% |
| IO Biotech, Inc. | 17.55 Million USD | -14551.794% |
| Jaguar Health, Inc. | 45.86 Million USD | -5508.226% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -7033.698% |
| Opthea Limited | 264.6 Million USD | -872.13% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1867.966% |
| ContextLogic Inc. | 206 Million USD | -1148.674% |
| MiMedx Group, Inc. | 96.33 Million USD | -2570.268% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -5256.439% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -72791.793% |
| NextCure, Inc. | 14.99 Million USD | -17051.89% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -63538.521% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -38424.322% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -5403.475% |
| Vaxcyte, Inc. | 167.44 Million USD | -1436.151% |
| PDS Biotechnology Corporation | 33.25 Million USD | -7634.023% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -993.587% |
| Pharming Group N.V. | 244.07 Million USD | -953.893% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -21475.818% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1912.872% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -38830.837% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -38830.837% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -3020.436% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -38621.496% |
| Acelyrin, Inc. | 86.35 Million USD | -2878.784% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -197882.437% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -17789.067% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1953.593% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -27036.502% |
| Senti Biosciences, Inc. | 52.57 Million USD | -4792.943% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -3640.013% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1597.733% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -131406.595% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -192497.959% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -1033.997% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -27360.969% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -1030.941% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -420.166% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -23468.527% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -9249.965% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -21150.169% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -428.62% |
| Immix Biopharma, Inc. | 3.72 Million USD | -69013.89% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -6702.785% |
| MEI Pharma, Inc. | 8.35 Million USD | -30687.181% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -8765.308% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -640.051% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1663.41% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1450.129% |
| Precigen, Inc. | 41.64 Million USD | -6076.806% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -5051.75% |
| AlloVir, Inc. | 45.01 Million USD | -5614.249% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1873.552% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1766.668% |
| ImmuCell Corporation | 18.81 Million USD | -13571.356% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -9013.119% |
| Onconetix, Inc. | 23.18 Million USD | -10996.508% |
| PureTech Health plc | 125.58 Million USD | -1948.262% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -28640.436% |
| Elevation Oncology, Inc. | 34.28 Million USD | -7403.264% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -105105.276% |
| Seer, Inc. | 39.36 Million USD | -6434.406% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -4059.959% |
| Innoviva, Inc. | 568.55 Million USD | -352.425% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -9347.146% |
| ESSA Pharma Inc. | 3.49 Million USD | -73497.046% |
| GlycoMimetics, Inc. | 6.9 Million USD | -37168.059% |
| GT Biopharma, Inc. | 6.63 Million USD | -38679.873% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -872.907% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -844.69% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -2961.277% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -26217.465% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -9367.662% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -79641.166% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -3387.019% |
| Aptose Biosciences Inc. | 15.8 Million USD | -16171.223% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -23200.201% |
| Soligenix, Inc. | 7.27 Million USD | -35258.116% |
| Century Therapeutics, Inc. | 175.94 Million USD | -1362.007% |
| Kura Oncology, Inc. | 51.66 Million USD | -4879.035% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -2020.899% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -62137.334% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -38792.129% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -918.325% |
| Autolus Therapeutics plc | 263.9 Million USD | -874.688% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -24439.868% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -2794.711% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -5384.699% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -628.985% |
| GRI Bio, Inc. | 2.69 Million USD | -95275.195% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -317626.86% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -8173.356% |
| IGM Biosciences, Inc. | 220.17 Million USD | -1068.273% |
| INmune Bio, Inc. | 18.86 Million USD | -13537.308% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -902.916% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -9555.008% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -94524.166% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -78316.476% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -4300.426% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -2575.016% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -871.639% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -212.537% |
| Verastem, Inc. | 71.18 Million USD | -3513.499% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -5130.741% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -6567.71% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -5156.824% |
| Histogen Inc. | 5.69 Million USD | -45051.29% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -58552.546% |
| Surrozen, Inc. | 8.14 Million USD | -31480.958% |
| Organovo Holdings, Inc. | 2.74 Million USD | -93505.131% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -819464.58% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -4474.558% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -15478.18% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -4933.499% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -310983.175% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1929.804% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -23687.373% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1604.743% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -98554.723% |
| Apollomics, Inc. | 14.15 Million USD | -18074.726% |
| Amarin Corporation plc | 279.58 Million USD | -820.025% |
| Mesoblast Limited | 188.79 Million USD | -1262.445% |
| Turnstone Biologics Corp. | 14.14 Million USD | -18081.149% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -1322.81% |
| Synaptogenix, Inc. | 5.52 Million USD | -46419.277% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -38592.374% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1412.139% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -29959.729% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -146268.456% |
| Exelixis, Inc. | 678.44 Million USD | -279.142% |
| Better Therapeutics, Inc. | 23.84 Million USD | -10688.814% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1468.017% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -332.89% |
| NLS Pharmaceutics AG | 10.68 Million USD | -23984.456% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -158328.409% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -6507.93% |
| Gritstone bio, Inc. | 125.91 Million USD | -1942.797% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -17427.044% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -50449.372% |
| Avid Bioservices, Inc. | 275.66 Million USD | -833.104% |
| Insmed Incorporated | 1.66 Billion USD | -54.792% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -33332.038% |
| MediWound Ltd. | 27.18 Million USD | -9361.393% |
| OmniAb, Inc. | 87.4 Million USD | -2843.1% |
| Alector, Inc. | 487.66 Million USD | -427.462% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -537.559% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -13860.754% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -6603.33% |
| Zai Lab Limited | 240.17 Million USD | -970.989% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -308.259% |
| Aura Biosciences, Inc. | 29.22 Million USD | -8701.002% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -2605.459% |
| Immunic, Inc. | 25.36 Million USD | -10039.818% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -3615.219% |
| Veracyte, Inc. | 93.71 Million USD | -2644.661% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -98203.036% |
| FibroGen, Inc. | 585.72 Million USD | -339.158% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -14697.613% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -393769.779% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -45382.948% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 66.404% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -31276.787% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -2961.423% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1421.288% |
| Galecto, Inc. | 5.89 Million USD | -43527.358% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -30951.05% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 1.762% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -8824.672% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -20280.865% |
| XBiotech Inc. | 8.39 Million USD | -30533.19% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -17427.044% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -4736.91% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -608.407% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -9468.029% |
| Theravance Biopharma, Inc. | 169 Million USD | -1422.017% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -111.605% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -414.016% |
| Vaxxinity, Inc. | 30.94 Million USD | -8212.658% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -164.504% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -42550.031% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -245.163% |
| NexImmune, Inc. | 5.08 Million USD | -50493.069% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -692498.426% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -83555.16% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 63.807% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -49807.917% |
| Scopus BioPharma Inc. | 7.45 Million USD | -34406.563% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -9682.722% |
| Ainos, Inc. | 7.39 Million USD | -34687.55% |
| Pluri Inc. | 34.11 Million USD | -7440.657% |
| Prothena Corporation plc | 135.01 Million USD | -1805.145% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -958.098% |
| Celularity Inc. | 102.92 Million USD | -2399.071% |
| Rallybio Corporation | 9.43 Million USD | -27160.163% |
| Cue Biopharma, Inc. | 24.44 Million USD | -10422.679% |
| MeiraGTx Holdings plc | 319.99 Million USD | -703.857% |
| Omeros Corporation | 403.25 Million USD | -537.881% |
| Humacyte, Inc. | 114.67 Million USD | -2143.056% |
| Immunocore Holdings plc | 228.15 Million USD | -1027.407% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -52664.492% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -3251.927% |
| Blueprint Medicines Corporation | 918.64 Million USD | -180.008% |
| CalciMedica, Inc. | 4.02 Million USD | -63759.707% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -14639.107% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1568.755% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -2897.389% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -825.966% |
| Pulmatrix, Inc. | 15.96 Million USD | -16013.945% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -16208.052% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -10353.828% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -925.593% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -4964.916% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -112.472% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -7993.223% |
| Nutriband Inc. | 1.07 Million USD | -238311.688% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -24091.376% |
| Vor Biopharma Inc. | 59.1 Million USD | -4252.106% |
| Roivant Sciences Ltd. | 773.95 Million USD | -232.355% |
| Evogene Ltd. | 17.99 Million USD | -14198.327% |
| ProKidney Corp. | 29.21 Million USD | -8704.316% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -3473.638% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -364769.649% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -36.177% |
| CorMedix Inc. | 11.91 Million USD | -21483.914% |
| BioLineRx Ltd. | 50.7 Million USD | -4973.309% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1621.053% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -2808.458% |
| Atai Life Sciences N.V. | 49.16 Million USD | -5132.23% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -8157.074% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -14220.616% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1963.825% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -45394.676% |
| MediciNova, Inc. | 3.89 Million USD | -65998.779% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -13972.263% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -170901.123% |
| GeoVax Labs, Inc. | 3.51 Million USD | -72978.294% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -547.504% |
| Biomea Fusion, Inc. | 30.69 Million USD | -8281.457% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 5.492% |
| Mereo BioPharma Group plc | 15.96 Million USD | -16014.954% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -8144.188% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -4283.254% |
| Absci Corporation | 58.3 Million USD | -4311.823% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -13404.142% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -7922.797% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -3385.932% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -2840.307% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -7517.024% |
| Allakos Inc. | 74.79 Million USD | -3339.184% |
| Imunon, Inc. | 8.53 Million USD | -30054.047% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -11331.799% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -2140.418% |
| BioAtla, Inc. | 48.98 Million USD | -5151.029% |
| NLS Pharmaceutics AG | 10.68 Million USD | -23984.456% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -92460.957% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1869.518% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -17995.456% |
| XOMA Corporation | 145.58 Million USD | -1666.911% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -7540.781% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -3640.992% |
| aTyr Pharma, Inc. | 31.59 Million USD | -8040.865% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -4060.699% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -5620.603% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -5214.386% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -89526.098% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -31430.563% |
| Akari Therapeutics, Plc | 4.58 Million USD | -56014.071% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -14405.443% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -55.946% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -636745.272% |
| UroGen Pharma Ltd. | 243.52 Million USD | -956.274% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -701.113% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -93045.572% |
| Orgenesis Inc. | 35.53 Million USD | -7138.691% |
| Entera Bio Ltd. | 1.37 Million USD | -186431.472% |
| GH Research PLC | 6.7 Million USD | -38286.345% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -37727.485% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -13563.386% |
| Xencor, Inc. | 283.55 Million USD | -807.137% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -86053.684% |
| Replimune Group, Inc. | 113.21 Million USD | -2172.041% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -68363.759% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -2384.564% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -636745.272% |
| Portage Biotech Inc. | 4.45 Million USD | -57703.798% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -170901.123% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -11059.518% |
| OncoCyte Corporation | 49.29 Million USD | -5117.796% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -62080.088% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -322448.039% |
| Purple Biotech Ltd. | 10 Million USD | -25609.835% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -44356.775% |
| scPharmaceuticals Inc. | 57.26 Million USD | -4392.183% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -20664.164% |
| HilleVax, Inc. | 78.9 Million USD | -3159.792% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -50836.02% |
| Tharimmune, Inc. | 1.81 Million USD | -141619.218% |
| Genprex, Inc. | 3.25 Million USD | -78944.394% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -9385.117% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -49026.604% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1248574.272% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -717312.731% |
| OKYO Pharma Limited | 7.42 Million USD | -34562.746% |
| Savara Inc. | 37.19 Million USD | -6816.189% |
| Curis, Inc. | 57.61 Million USD | -4364.815% |
| Daré Bioscience, Inc. | 26.32 Million USD | -9669.401% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -6461.945% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -178034.972% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -12255.392% |
| BeiGene, Ltd. | 2.23 Billion USD | -15.155% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -11982.166% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -880.297% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -11991.139% |
| Erasca, Inc. | 78.61 Million USD | -3172.149% |
| bluebird bio, Inc. | 424.62 Million USD | -505.776% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -392461.793% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -36.095% |
| DBV Technologies S.A. | 42.8 Million USD | -5909.974% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -392461.793% |
| Moderna, Inc. | 4.57 Billion USD | 43.739% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -36672.966% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -155230.254% |
| Molecular Templates, Inc. | 31.17 Million USD | -8152.122% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -14968.946% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -337.384% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1965.997% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -9275.183% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -6955.818% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -4523.473% |
| MacroGenics, Inc. | 154.2 Million USD | -1568.062% |
| RenovoRx, Inc. | 4.46 Million USD | -57496.708% |
| Adicet Bio, Inc. | 37.12 Million USD | -6829.604% |
| Prime Medicine, Inc. | 60.78 Million USD | -4132.098% |
| Aditxt, Inc. | 28.53 Million USD | -8915.522% |
| Adagene Inc. | 45.16 Million USD | -5594.723% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1423394.613% |
| Quantum-Si incorporated | 26.63 Million USD | -9558.928% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -268.749% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -84446.308% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -2137.514% |
| SciSparc Ltd. | 1.59 Million USD | -161170.784% |
| Vericel Corporation | 127.7 Million USD | -1914.227% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -46123.145% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -2913.503% |
| Generation Bio Co. | 171.63 Million USD | -1398.729% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -22170.727% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -6049.193% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -917.922% |
| Invivyd, Inc. | 51.71 Million USD | -4874.124% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -2696.644% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -39441.426% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -3307.159% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -251836.239% |
| 2seventy bio, Inc. | 310.12 Million USD | -729.427% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1226.076% |
| Clene Inc. | 38.95 Million USD | -6503.859% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -7018.919% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -900.976% |
| GeoVax Labs, Inc. | 3.51 Million USD | -72978.294% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -1251.954% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -21019.379% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1197.016% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -20993.163% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -5246.53% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -4767.942% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -595.482% |
| Evaxion Biotech A/S | 17.61 Million USD | -14500.664% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1498.387% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1579.18% |
| Trevena, Inc. | 48.26 Million USD | -5229.802% |
| Surrozen, Inc. | 8.14 Million USD | -31480.958% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -11811.41% |
| Cingulate Inc. | 10.36 Million USD | -24726.778% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -93437.055% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -6797.643% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -71620.47% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -19460.981% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -710.927% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -10251.6% |
| Clearmind Medicine Inc. | 3.61 Million USD | -71153.831% |
| Kronos Bio, Inc. | 54.2 Million USD | -4645.796% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -5367.91% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -11201.842% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -12715.849% |
| Statera Biopharma, Inc. | 22.67 Million USD | -11243.348% |
| ImmunityBio, Inc. | 1.09 Billion USD | -135.904% |
| Korro Bio, Inc. | 51.75 Million USD | -4870.376% |
| Kineta, Inc. | 7.22 Million USD | -35517.128% |
| BioVie Inc. | 9.7 Million USD | -26412.415% |
| Codexis, Inc. | 49.94 Million USD | -5050.1% |
| Celularity Inc. | 102.92 Million USD | -2399.071% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -2572.571% |
| Celcuity Inc. | 51.45 Million USD | -4899.544% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -745066.196% |
| Cibus, Inc. | 206.11 Million USD | -1147.965% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -5955.96% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -9666.009% |
| IN8bio, Inc. | 8.77 Million USD | -29223.632% |
| Kodiak Sciences Inc. | 213.59 Million USD | -1104.297% |
| Annexon, Inc. | 47.11 Million USD | -5359.207% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2772.728% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -2569.104% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -18690.774% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 1.195% |
| Eyenovia, Inc. | 19.78 Million USD | -12904.209% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -1352.554% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -33388.725% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -10573.758% |
| Arcellx, Inc. | 339.75 Million USD | -657.102% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -21519.339% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -947.597% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -26798.139% |
| Moolec Science SA | 13.94 Million USD | -18345.345% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -5860.95% |
| Geron Corporation | 146.12 Million USD | -1660.297% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -4990.376% |
| Royalty Pharma plc | 6.29 Billion USD | 59.155% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -6366.887% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -873614.87% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -104451.795% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1259.866% |
| Humacyte, Inc. | 114.67 Million USD | -2143.056% |
| Structure Therapeutics Inc. | 29.05 Million USD | -8754.32% |
| 89bio, Inc. | 59.96 Million USD | -4189.76% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -9620.247% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -214972.659% |
| Genelux Corporation | 8.42 Million USD | -30449.513% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -37418.509% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1786.948% |
| Notable Labs, Ltd. | 4.42 Million USD | -58004.111% |
| Liquidia Corporation | 73.13 Million USD | -3417.008% |
| Mustang Bio, Inc. | 17.61 Million USD | -14499.404% |
| Immunovant, Inc. | 48.95 Million USD | -5154.354% |
| Quantum-Si incorporated | 26.63 Million USD | -9558.928% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -6601.584% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -82796.197% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -3382.581% |
| Acasti Pharma Inc. | 11.55 Million USD | -22157.238% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -11277.83% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -94524.166% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -6875.266% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -188643.009% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -42096.014% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -10257.435% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -10995.018% |
| PepGen Inc. | 34.63 Million USD | -7327.649% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -21081.398% |
| United Therapeutics Corporation | 1.18 Billion USD | -117.583% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -36730.885% |
| Solid Biosciences Inc. | 38.45 Million USD | -6588.515% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -29959.729% |
| Immuneering Corporation | 12 Million USD | -21320.661% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -819464.58% |
| Silo Pharma, Inc. | 1.56 Million USD | -163815.005% |
| Belite Bio, Inc | 4.21 Million USD | -60984.517% |
| XOMA Corporation | 145.58 Million USD | -1666.911% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -105841.886% |
| Bionomics Limited | 10.15 Million USD | -25220.796% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -11869.052% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11126.243% |
| uniQure N.V. | 624.01 Million USD | -312.21% |
| Cassava Sciences, Inc. | 14.19 Million USD | -18020.951% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1423394.613% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1411.463% |
| Forte Biosciences, Inc. | 3.66 Million USD | -70065.548% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -987020.802% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -38024.633% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -33388.725% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -14697.613% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -24240.168% |
| Altimmune, Inc. | 16.54 Million USD | -15450.868% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -316.423% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11126.243% |
| Compugen Ltd. | 55.77 Million USD | -4511.867% |
| Peak Bio, Inc. | 20.75 Million USD | -12294.468% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -2228.625% |
| Benitec Biopharma Inc. | 4.96 Million USD | -51739.359% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1529.638% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -3321.754% |
| Zura Bio Limited | 21.29 Million USD | -11980.918% |
| PolyPid Ltd. | 17.46 Million USD | -14625.607% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -2188.516% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -3321.754% |
| Instil Bio, Inc. | 99.8 Million USD | -2477.398% |
| argenx SE | 444.95 Million USD | -478.102% |
| Immunome, Inc. | 28.65 Million USD | -8875.745% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -30753.652% |
| Verona Pharma plc | 58.84 Million USD | -4271.559% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -17672.881% |
| Shattuck Labs, Inc. | 14.85 Million USD | -17211.185% |
| CervoMed Inc. | 2.59 Million USD | -98995.52% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -52675.318% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -20096.836% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -24316.412% |
| Moolec Science SA | 13.94 Million USD | -18345.345% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -109661.665% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -4526.775% |
| AnaptysBio, Inc. | 364.28 Million USD | -606.113% |
| Design Therapeutics, Inc. | 11.95 Million USD | -21414.461% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -20179.636% |
| NeurAxis, Inc. | 1.91 Million USD | -134380.92% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -6507.76% |
| Lumos Pharma, Inc. | 13.33 Million USD | -19192.5% |
| Achilles Therapeutics plc | 19.08 Million USD | -13376.549% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -17672.881% |
| 180 Life Sciences Corp. | 5.38 Million USD | -47647.711% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -10804.994% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -11201.842% |
| Nutriband Inc. | 1.07 Million USD | -238311.688% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -8306.657% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -17626.339% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -541.026% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -7821.255% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -19612.239% |
| Palisade Bio, Inc. | 2.73 Million USD | -93812.705% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -48867.619% |
| Beam Therapeutics Inc. | 478.38 Million USD | -437.699% |
| Neurogene Inc. | 36.54 Million USD | -6937.864% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -546.378% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1508.784% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -5298.256% |
| Sesen Bio, Inc. | 30.98 Million USD | -8201.927% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -9808.205% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -33735.779% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1214.139% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -1239.326% |
| Athira Pharma, Inc. | 30.05 Million USD | -8457.97% |
| Vaccinex, Inc. | 5.94 Million USD | -43189.616% |
| HCW Biologics Inc. | 15.05 Million USD | -16989.282% |
| XOMA Corporation | 145.58 Million USD | -1666.911% |
| Nektar Therapeutics | 267.04 Million USD | -863.231% |
| Arvinas, Inc. | 644.6 Million USD | -299.049% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -14405.443% |
| Merus N.V. | 102.15 Million USD | -2418.105% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1657.615% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -2604.236% |
| Rezolute, Inc. | 11.73 Million USD | -21821.502% |
| Clene Inc. | 38.95 Million USD | -6503.859% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -90238.1% |
| BeyondSpring Inc. | 48.26 Million USD | -5229.029% |
| Synlogic, Inc. | 32.89 Million USD | -7719.635% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -17502.607% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -157321.603% |
| Peak Bio, Inc. | 20.75 Million USD | -12294.468% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -3953.435% |
| Krystal Biotech, Inc. | 39.71 Million USD | -6376.983% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -582.944% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -2483.403% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -594333.66% |
| MannKind Corporation | 721.36 Million USD | -256.583% |
| Ikena Oncology, Inc. | 22.33 Million USD | -11416.763% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -123211.074% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -2407.329% |
| Gossamer Bio, Inc. | 249.14 Million USD | -932.43% |
| CohBar, Inc. | 1.03 Million USD | -248755.886% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -23964.637% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -13404.142% |
| Legend Biotech Corporation | 589.93 Million USD | -336.027% |
| Mural Oncology plc | 37.92 Million USD | -6681.979% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1839.345% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -111965.226% |
| Disc Medicine, Inc. | 22.87 Million USD | -11144.892% |
| Champions Oncology, Inc. | 28.03 Million USD | -9075.206% |
| REGENXBIO Inc. | 262.22 Million USD | -880.928% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -76470.392% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -20422.331% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -19050.837% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -12030.483% |
| Vaxart, Inc. | 34.02 Million USD | -7459.938% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -12515.801% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -8915.42% |
| Cellectis S.A. | 249.57 Million USD | -930.66% |
| Longeveron Inc. | 5.33 Million USD | -48096.908% |
| Repare Therapeutics Inc. | 41.81 Million USD | -6050.958% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -6.944% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -4160.981% |
| Revolution Medicines, Inc. | 262.39 Million USD | -880.297% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -121982.06% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -29719.951% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -21697.043% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -18217.09% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -119484.798% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 50.051% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1991.905% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -46123.145% |
| Veru Inc. | 32.81 Million USD | -7739.247% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -37347.503% |
| Cingulate Inc. | 10.36 Million USD | -24726.778% |
| Passage Bio, Inc. | 39.26 Million USD | -6451.549% |
| Context Therapeutics Inc. | 4.19 Million USD | -61265.551% |
| Exicure, Inc. | 8.54 Million USD | -29988.537% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -8617.192% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -24430.507% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -11570.382% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1478.215% |
| Nuvalent, Inc. | 31.82 Million USD | -7983.05% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -40334.137% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -3981.541% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -14190.383% |
| OmniAb, Inc. | 87.4 Million USD | -2843.1% |
| Anew Medical, Inc. | 8.24 Million USD | -31110.043% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -6618.02% |
| Lipocine Inc. | 2.63 Million USD | -97644.363% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -9690.914% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -6296.77% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -9555.008% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -2885.664% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -47525.792% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -3008.595% |
| Ocugen, Inc. | 23.98 Million USD | -10625.385% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -5442.847% |
| Q32 Bio Inc. | 233.12 Million USD | -1003.372% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -28272.7% |
| Alumis Inc. Common Stock | 53.5 Million USD | -4707.8% |
| Equillium, Inc. | 27.95 Million USD | -9100.805% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -1145.096% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -45615.695% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -41841.667% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -1534.993% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -3604.678% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -25689.224% |
| Dominari Holdings Inc. | 4.63 Million USD | -55396.634% |
| Edesa Biotech, Inc. | 1.84 Million USD | -139572.965% |
| vTv Therapeutics Inc. | 29.56 Million USD | -8599.797% |
| Bio-Techne Corporation | 744.34 Million USD | -245.577% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1939.881% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -646.763% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -6239.542% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -8783.065% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -2685.047% |
| Nkarta, Inc. | 105.6 Million USD | -2335.861% |
| BioCardia, Inc. | 4.59 Million USD | -55940.719% |
| Iterum Therapeutics plc | 32.66 Million USD | -7775.418% |